Forex News
Iovance Biotherapeutics, Inc. Grants 179750 Options
A single-source account says Iovance Biotherapeutics, Inc. granted 179750 stock options on September 17, 2026.
PipDig Newsroom
- The stock options have an exercise price of 10.02.
- Iovance Biotherapeutics, Inc. lists 95 treatment centers.
- Amtagvi® is FDA-approved.
Grant Terms
Iovance Biotherapeutics, Inc. granted 179750 stock options on September 17, 2026. The exercise price is 10.02.
Product Status
Iovance Biotherapeutics, Inc. identifies its product as Amtagvi®. Amtagvi® is FDA-approved.
Treatment Centers
Iovance Biotherapeutics, Inc. lists 95 treatment centers.